Acelyrin Inc (SLRN)
4.125
+0.08
(+1.85%)
USD |
NASDAQ |
May 31, 16:00
4.125
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Total Assets (Quarterly): 697.48M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 697.48M |
December 31, 2023 | 742.69M |
September 30, 2023 | 800.49M |
Date | Value |
---|---|
June 30, 2023 | 835.13M |
March 31, 2023 | 298.52M |
December 31, 2022 | 319.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
298.52M
Minimum
Mar 2023
835.13M
Maximum
Jun 2023
615.71M
Average
720.09M
Median
Total Assets (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | 417.22M |
Eagle Pharmaceuticals Inc | 404.82M |
Avalo Therapeutics Inc | 123.73M |
Design Therapeutics Inc | 278.79M |
CEL-SCI Corp | 30.05M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 53.42M |
Shareholders Equity (Quarterly) | 644.07M |